Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Zurletrectinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    InnoCare's Zurletrectinib Gets Priority Review from China's NMPA
    InnoCare's Zurletrectinib Gets Priority Review from China's NMPA

    01 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250501565030/en/InnoCares-Zurletrectinib-Receives-Priority-Review-from-Chinas-NMPA

    BUSINESSWIRE
    01 May 2025
    Share Share
    InnoCare Announces Acceptance of NDA for Zurletrectinib in China
    InnoCare Announces Acceptance of NDA for Zurletrectinib in China

    16 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250415365931/en/InnoCare-Announces-the-Acceptance-of-New-Drug-Application-for-pan-TRK-Inhibitor-Zurletrectinib-in-China

    BUSINESSWIRE
    16 Apr 2025
    Share Share
    Zurletrectinib Shows Strong Activity Against NTRK Fusion-Positive Tumors
    Zurletrectinib Shows Strong Activity Against NTRK Fusion-Positive Tumors

    30 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240730463296/en

    BUSINESSWIRE
    30 Jul 2024
    Share Share
    InnoCare Announces First Pediatric Patient Dosed in Trial of Zurletrectinib
    InnoCare Announces First Pediatric Patient Dosed in Trial of Zurletrectinib

    23 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240123487367/en

    BUSINESSWIRE
    23 Jan 2024
    Share Share